Main Article Content
Abstract
Keywords
Article Details
References
- Brunton LL, Chabner BA, dan Knollmann BC, 2010. Goodman and Gilman's The Pharmacological Basis of Therapeutics 12th Edition. pp-397-414
- Corryell W, 2013. Bipolar Disorders. Merck Manual Professional. Diakses dari: http://www.merckmanuals.com/professional/psychiatric-disorders/mood- disorders/bipolar-disorders
- DeBattista C, Eisendrath SJ, dan Lichtmacher JE, 2015. Mood Disorder. Psychiatric Disorders. In: CURRENT Medical Diagnosis and Treatment 44th Edition. McGraw-Hill. pp-1051-1053
- Gajwani P, 2009. Treatment-refractory bipolar disorder: classification to aid in clinical management. Expert Opinion on Pharmacotherapy. 10:12, 1907-1915
- Ghaleiha A, Haghighi M, Sharifmehr M, et al, 2014. Oral Loading of Sodium Valproate Compared to Intravenous Loading and Oral Maintenance in Acutely Manic Bipolar Patients. Neuropsychobiology 70:29-35
- Gijsman HJ, Geddes JR, Rendell JM et al, 2004. Antidepressants for Bipolar Depression: A Systematic Review of Randomized, Controlled Trials. Am J Psychiatry. 161:1537-1547
- Grunze H, Vieta E, Goodwin GM, et al (2018). The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders: Update 2012 on the long-term treatment of bipolar disorder. The World Journal of Biological Psychiatry. 14: 154-219
- Lacy, C.F., Amstrong, L.L., Goldman, N.P., et al, 2009. Drug Information Handbook 18th edition. APhA : Lexi-Comp.
- Lukasiewicz M, Gerard S, Besnard A, et al, 2013. Young Mania Rating Scale: how to interpret the numbers? Determinationof a severity threshold and of the minimal clinically significant difference in the EMBLEM cohort. Int. J. Methods Psychiatr. Res. 22(1): 46-58
- Moosavi SM, Ahmadi M, dan Monajemi MB, 2014. Risperidone Versus Risperidone PlusSodium Valproate for Treatment of Bipolar Disorders: A Randomized, Double-Blind Clinical-Trial. Global Journal of Health Science; Vol. 6, No. 6
- Peselow ED, Naghdechi L, Pizano D, IsHak WW, 2016. Polypharmacy in Maintenance of Bipolar Disorder. Clinical Neuropharmacology. 39(3): 132-134
- Pytliak M, Vargova V, Mechirova V, et al, 2011. Serotonin Receptors-From Molecular Biology to Clinical Applications. Physiol. Res. 60: 15-25
- Raza MU, Tufan T, Wang Y, Hill C, dan Zhu MY, 2016. DNA Damage in Major Psychiatric Diseases. Neurotox Res. 30: 251-257
- Reus VI, 2015. Mental Disorder. In: Harrison’s Principles of Internal Medicine 19th Edition.McGraw-Hill. pp-2717-2719
- Truman CJ, Goldberg JF, Ghaemi SN et al, 2007. Self-reported history of manic/hypomanic switch associated with antidepressant use: data from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). J Clin Psychiatry. 68(10):1472-9
- WHO, 2001. Global Burden of Disease 2000 Study. World Health Report
- Widmaier EP, Raff H, dan Strang KT, 2014. Vander’s Human Physiology: Mechanism of Body Function. 13th Edition. pp-167-172
References
Brunton LL, Chabner BA, dan Knollmann BC, 2010. Goodman and Gilman's The Pharmacological Basis of Therapeutics 12th Edition. pp-397-414
Corryell W, 2013. Bipolar Disorders. Merck Manual Professional. Diakses dari: http://www.merckmanuals.com/professional/psychiatric-disorders/mood- disorders/bipolar-disorders
DeBattista C, Eisendrath SJ, dan Lichtmacher JE, 2015. Mood Disorder. Psychiatric Disorders. In: CURRENT Medical Diagnosis and Treatment 44th Edition. McGraw-Hill. pp-1051-1053
Gajwani P, 2009. Treatment-refractory bipolar disorder: classification to aid in clinical management. Expert Opinion on Pharmacotherapy. 10:12, 1907-1915
Ghaleiha A, Haghighi M, Sharifmehr M, et al, 2014. Oral Loading of Sodium Valproate Compared to Intravenous Loading and Oral Maintenance in Acutely Manic Bipolar Patients. Neuropsychobiology 70:29-35
Gijsman HJ, Geddes JR, Rendell JM et al, 2004. Antidepressants for Bipolar Depression: A Systematic Review of Randomized, Controlled Trials. Am J Psychiatry. 161:1537-1547
Grunze H, Vieta E, Goodwin GM, et al (2018). The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders: Update 2012 on the long-term treatment of bipolar disorder. The World Journal of Biological Psychiatry. 14: 154-219
Lacy, C.F., Amstrong, L.L., Goldman, N.P., et al, 2009. Drug Information Handbook 18th edition. APhA : Lexi-Comp.
Lukasiewicz M, Gerard S, Besnard A, et al, 2013. Young Mania Rating Scale: how to interpret the numbers? Determinationof a severity threshold and of the minimal clinically significant difference in the EMBLEM cohort. Int. J. Methods Psychiatr. Res. 22(1): 46-58
Moosavi SM, Ahmadi M, dan Monajemi MB, 2014. Risperidone Versus Risperidone PlusSodium Valproate for Treatment of Bipolar Disorders: A Randomized, Double-Blind Clinical-Trial. Global Journal of Health Science; Vol. 6, No. 6
Peselow ED, Naghdechi L, Pizano D, IsHak WW, 2016. Polypharmacy in Maintenance of Bipolar Disorder. Clinical Neuropharmacology. 39(3): 132-134
Pytliak M, Vargova V, Mechirova V, et al, 2011. Serotonin Receptors-From Molecular Biology to Clinical Applications. Physiol. Res. 60: 15-25
Raza MU, Tufan T, Wang Y, Hill C, dan Zhu MY, 2016. DNA Damage in Major Psychiatric Diseases. Neurotox Res. 30: 251-257
Reus VI, 2015. Mental Disorder. In: Harrison’s Principles of Internal Medicine 19th Edition.McGraw-Hill. pp-2717-2719
Truman CJ, Goldberg JF, Ghaemi SN et al, 2007. Self-reported history of manic/hypomanic switch associated with antidepressant use: data from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). J Clin Psychiatry. 68(10):1472-9
WHO, 2001. Global Burden of Disease 2000 Study. World Health Report
Widmaier EP, Raff H, dan Strang KT, 2014. Vander’s Human Physiology: Mechanism of Body Function. 13th Edition. pp-167-172